SPHK2 and alcoholic fatty liver disease: Intriguingly, SphK2 is likely a metabolically protective factor in the liver, as Sphk2−/− predisposes to non-alcoholic and alcoholic fatty liver diseases [42, 43], whereas adenoviral overexpression of SphK2 primarily in the liver improves insulin resistance [41].